TAL1/SCL induces leukemia by inhibiting the transcriptional activity of E47/HEB

Cancer Cell

Volumn 5, Issue 6, 2004, Pages 587-596

  O'Neil, Jennifer ^a   Shank, Jennifer ^a   Cusson, Nicole ^a   Murre, Cornelis ^b   Kelliher, Michelle ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE DEACETYLASE INHIBITOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENE REPRESSION; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HETEROZYGOSITY; HUMAN; HUMAN CELL; LEUKEMIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TAL1 GENE; THYMOCYTE; WILD TYPE;

ANIMALIA;

EID: 2942579675     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2004.05.023     Document Type: Article

References (46)

1. Bain G., Maandag E.C., Izon D.J., Amsen D., Kruisbeek A.M., Weintraub B.C., Krop I., Schlissel M.S., Feeney A.J., van Roon M. E2A proteins are required for proper B cell development and initiation of immunoglobulin gene rearrangements. Cell. 79:1994;885-892
2. Bain G., Engel I., Robanus Maandag E.C., te Riele H.P., Voland J.R., Sharp L.L., Chun J., Huey B., Pinkel D., Murre C. E2A deficiency leads to abnormalities in αβ T-cell development and to rapid development of T-cell lymphomas. Mol. Cell. Biol. 17:1997;4782-4791
3. Barndt R., Dai M.F., Zhuang Y. A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during αβ thymopoiesis. J. Immunol. 163:1999;3331-3343
4. Bash R.O., Hall S., Timmons C.F., Crist W.M., Amylon M., Smith R.G., Baer R. Does activation of the TAL1 gene occur in a majority of patients with T-cell acute lymphoblastic leukemia? A pediatric oncology group study. Blood. 86:1995;666-676
5. Bradney C., Hjelmeland M., Komatsu Y., Yoshida M., Yao T.P., Zhuang Y. Regulation of E2A activities by histone acetyltransferases in B lymphocyte development. J. Biol. Chem. 278:2002;2370-2376
6. Cohen-Kaminsky S., Maouche-Chretien L., Vitelli L., Vinit M.A., Blanchard I., Yamamoto M., Peschle C., Romeo P.H. Chromatin immunoselection defines a TAL1 target gene. EMBO J. 17:1998;5151-5160
7. Eckner R., Yao T.P., Oldread E., Livingston D.M. Interaction and functional collaboration of p300/CBP and bHLH proteins in muscle and B-cell differentiation. Genes Dev. 10:1996;2478-2490
8. Engel I., Murre C. Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas. Proc. Natl. Acad. Sci. USA. 96:1999;996-1001
9. Engel I., Murre C. E2A proteins enforce a proliferation checkpoint in developing thymocytes. EMBO J. 23:2004;202-211
10. Ferrando A.A., Neuberg D.S., Staunton J., Loh M.L., Huard C., Raimondi S.C., Behm F.G., Pui C.H., Downing J.R., Gilliland D.G., et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell. 1:2002;75-87
11. He Y.W. Orphan nuclear receptors in T lymphocyte development. J. Leukoc. Biol. 72:2002;440-446
12. Herblot S., Steff A.M., Hugo P., Aplan P.D., Hoang T. SCL and LMO1 alter thymocyte differentiation. inhibition of E2A-HEB function and pre-T α chain expression Nat. Immunol. 1:2000;138-144
13. Hsu H.L., Cheng J.T., Chen Q., Baer R. Enhancer-binding activity of the tal1 oncoprotein in association with the E47/E12 helix-loop-helix proteins. Mol. Cell. Biol. 11:1991;3037-3042
14. Hsu H.L., Wadman I., Baer R. Formation of in vivo complexes between the TAL1 and E2A polypeptides of leukemic T cells. Proc. Natl. Acad. Sci. USA. 91:1994;3181-3185. a
15. Hsu H.L., Wadman I., Tsan J.T., Baer R. Positive and negative transcriptional control by the TAL1 helix-loop-helix protein. Proc. Natl. Acad. Sci. USA. 91:1994;5947-5951. b
16. Huang S., Brandt S.J. mSin3A regulates murine erythroleukemia cell differentiation through association with the TAL1 (or SCL) transcription factor. Mol. Cell. Biol. 20:2000;2248-2259
17. Kelliher M.A., Seldin D.C., Leder P. Tal1 induces T cell acute lymphoblastic leukemia accelerated by casein kinase IIalpha. EMBO J. 15:1996;5160-5166
18. Kim D., Xu M., Nie L., Peng X.C., Jimi E., Voll R.E., Nguyen T., Ghosh S., Sun X.H. Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-κB activities. Immunity. 16:2002;9-21
19. Kohn D.B., Sadelain M., Glorioso J.C. Occurrence of leukaemia following gene therapy of X-linked SCID. Nat. Rev. Cancer. 3:2003;477-488
20. Kordes U., Krappmann D., Heissmeyer V., Ludwig W.D., Scheidereit C. Transcription factor NF-κB is constitutively activated in acute lymphoblastic leukemia cells. Leukemia. 14:2000;399-402
21. Larson R.C., Lavenir I., Larson T.A., Baer R., Warren A.J., Wadman I., Nottage K., Rabbitts T.H. Protein dimerization between Lmo2 (Rbtn2) and Tal1 alters thymocyte development and potentiates T cell tumorigenesis in transgenic mice. EMBO J. 15:1996;1021-1027
22. Littman D.R., Sun Z., Unutmaz D., Sunshine M.J., Petrie H.T., Zou Y.R. Role of the nuclear hormone receptor ROR gamma in transcriptional regulation, thymocyte survival, and lymphoid organogenesis. Cold Spring Harb. Symp. Quant. Biol. 64:1999;373-381
23. Malissen M., Minard K., Mjolsness S., Kronenberg M., Goverman J., Hunkapiller T., Prystowsky M.B., Yoshikai Y., Fitch F., Mak T.W., et al. Mouse T cell antigen receptor. structure and organization of constant and joining gene segments encoding the β polypeptide Cell. 37:1984;1101-1110
24. Mikkola H., Klintman J., Yang H., Hock H., Schlaeger T.M., Fujiwara Y., Orkin S.H. Haematopoietic stem cells retain long-term repopulating activity and multipotency in the absence of stem-cell leukaemia SCL/tal1 gene. Nature. 421:2003;547-551
25. O'Neil J., Billa M., Oikemus S., Kelliher M. The DNA binding activity of TAL1 is not required to induce leukemia/lymphoma in mice. Oncogene. 20:2001;3897-3905
26. O'Neil J., Ventura J.J., Cusson N., Kelliher M. NF-κB activation in premalignant mouse tal1/scl thymocytes and tumors. Blood. 102:2003;2593-2596
27. Ono Y., Fukuhara N., Yoshie O. TAL1 and LIM-only proteins synergistically induce retinaldehyde dehydrogenase 2 expression in T-cell acute lymphoblastic leukemia by acting as cofactors for GATA3. Mol. Cell. Biol. 18:1998;6939-6950
28. Petersson K., Ivars F., Sigvardsson M. The pTalpha promoter and enhancer are direct targets for transactivation by Ebox-binding proteins. Eur. J. Immunol. 32:2002;911-920
29. Rabbitts T.H. LMO T-cell translocation oncogenes typify genes activated by chromosomal translocations that alter transcription and developmental processes. Genes Dev. 12:1998;2651-2657
30. Reizis B., Leder P. The upstream enhancer is necessary and sufficient for the expression of the pre-T cell receptor alpha gene in immature T lymphocytes. J. Exp. Med. 194:2001;979-990
31. Sawada S., Littman D.R. A heterodimer of HEB and an E12-related protein interacts with the CD4 enhancer and regulates its activity in T-cell lines. Mol. Cell. Biol. 13:1993;5620-5628
32. Schlissel M., Voronova A., Baltimore D. Helix-loop-helix transcription factor E47 activates germ-line immunoglobulin heavy-chain gene transcription and rearrangement in a pre-T-cell line. Genes Dev. 5:1991;1367-1376
33. Shinkai Y., Rathbun G., Lam K.P., Oltz E.M., Stewart V., Mendelsohn M., Charron J., Datta M., Young F., Stall A.M., et al. RAG2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 68:1992;855-867
34. Shivdasani R.A., Mayer E.L., Orkin S.H. Absence of blood formation in mice lacking the T-cell leukaemia oncoprotein tal1/SCL. Nature. 373:1995;432-434
35. Sun Z., Unutmaz D., Zou Y.R., Sunshine M.J., Pierani A., Brenner-Morton S., Mebius R.E., Littman D.R. Requirement for RORgamma in thymocyte survival and lymphoid organ development. Science. 288:2000;2369-2373
36. Takeuchi A., Yamasaki S., Takase K., Nakatsu F., Arase H., Onodera M., Saito T. E2A and HEB activate the pre-TCR alpha promoter during immature T cell development. J. Immunol. 167:2001;2157-2163
37. Tremblay M., Herblot S., Lecuyer E., Hoang T. Regulation of pT alpha gene expression by a dosage of E2A, HEB, and SCL. J. Biol. Chem. 278:2003;12680-12687
38. Ueda E., Kurebayashi S., Sakaue M., Backlund M., Koller B., Jetten A.M. High incidence of T-cell lymphomas in mice deficient in the retinoid-related orphan receptor RORgamma. Cancer Res. 62:2002;901-909
39. Valge-Archer V.E., Osada H., Warren A.J., Forster A., Li J., Baer R., Rabbitts T.H. The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. Proc. Natl. Acad. Sci. USA. 91:1994;8617-8621
40. Voronova A.F., Lee F. The E2A and tal1 helix-loop-helix proteins associate in vivo and are modulated by Id proteins during interleukin 6-induced myeloid differentiation. Proc. Natl. Acad. Sci. USA. 91:1994;5952-5956
41. Visvader J.E., Fujiwara Y., Orkin S.H. Unsuspected role for the T-cell leukemia protein SCL/tal1 in vascular development. Genes Dev. 12:1998;473-479
42. Wadman I.A., Osada H., Grutz G.G., Agulnick A.D., Westphal H., Forster A., Rabbitts T.H. The LIM-only protein Lmo2 is a bridging molecule assembling an erythroid, DNA-binding complex which includes the TAL1, E47, GATA-1 and Ldb1/NLI proteins. EMBO J. 16:1997;3145-3157
43. Yan W., Young A.Z., Soares V.C., Kelley R., Benezra R., Zhuang Y. High incidence of T-cell tumors in E2A-null mice and E2A/Id1 double-knockout mice. Mol. Cell. Biol. 17:1997;7317-7327
44. Yu W., Nagaoka H., Jankovic M., Misulovin Z., Suh H., Rolink A., Melchers F., Meffre E., Nussenzweig M.C. Continued RAG expression in late stages of B cell development and no apparent re-induction after immunization. Nature. 400:1999;682-687
45. Zhang Y., Iratni R., Erdjument-Bromage H., Tempst P., Reinberg D. Histone deacetylases and SAP18, a novel polypeptide, are components of a human Sin3 complex. Cell. 89:1997;357-364
46. Zhuang Y., Cheng P., Weintraub H. B-lymphocyte development is regulated by the combined dosage of three basic helix-loop-helix genes, E2A, E2-2, and HEB. Mol. Cell. Biol. 16:1996;2898-2905